Terms: = Thyroid cancer AND PALB2, ENSG00000083093, 79728 AND Treatment
2 results:
1. Personalized Systemic Therapies in Hereditary cancer Syndromes.
Mastrodomenico L; Piombino C; Riccò B; Barbieri E; Venturelli M; Piacentini F; Dominici M; Cortesi L; Toss A
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980956
[TBL] [Abstract] [Full Text] [Related]
2. Pentagalloylglucose disrupts the palb2-BRCA2 interaction and potentiates tumor sensitivity to PARP inhibitor and radiotherapy.
Zeng J; Han J; Liu Z; Yu M; Li H; Yu J
Cancer Lett; 2022 Oct; 546():215851. PubMed ID: 35926819
[TBL] [Abstract] [Full Text] [Related]
